From Genspect:
"BIG NEWS! 🧵US-@TheEndoSociety told CNN yesterday that it has initiated a 3-yr review of its clinical guidelines for "gender-affirming care". The recommendations for adolescents in their current guidelines, published in 2017, all rank "low" or "very low" according to the GRADE system of determining evidence quality & making recommendations. Yet they are considered the "gold standard" within the US medical community! "
"The committee revising the guidelines is led by activist-clinician & @WPATH endocrinologist, Dr. Joshua Safer, executive director of the Mount Sinai Center for Transgender Medicine & Surgery in NY. Are all the members of the committee, like Safer, clinicians whose careers and reputations depend upon the continued success of "'gender medicine"? Financial conflicts of interest are a major concern here!
Will this be a rigorous, independent review? If so, it MUST align with the systematic reviews already conducted by Florida, Sweden, Finland, the UK, and now, Germany. (Spoiler alert: these ALL found that evidence doesn't support the off-label use of puberty blockers and/or cross sex hormones for youth gender dysphoria!)"
https://twitter.com/genspect/status/1762609815417692565?t=7iQ8Jh56-Ju7J0OOJzm58w&s=19
Links follow